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INTRODUCTION 
 
Chronic Ulcers pose significant and challenging health as well as 
economic problems, as it needs long term surgical and nursing care 
whether it is á Burn wound, Diabetic ulcer, Decubitus ulcer, or even 
otherwise. Ulcers are also susceptible to complications like infection and 
thus sepsis and limb loss. Management of chronic ulcers require dressing, 
many times a day. The aim of dressing is to protect from contamination, 
infection and injury, absorption of drainage from the ulcer, and 
immobilization of the wound. Many agents have been used according to 
interest like saline, Betadine, Dakin’s Solution, Acriflavin, Bactatin and 
various antibiotic solutions. 
This study aims to evaluate the efficacy of various dressings in the 
management of diabetic foot ulcer,namely: 
  A)collagen dressing 
 b)alginate dressing 
 c)topical hydrogels 
 d)conventional  saline dressing 
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                  AIMS AND OBJECTIVES 
 
To compare  efficacy of following dressings in management of diabetic foot 
ulcer: 
 a)collagen dressing 
 
 b)alginate dressing 
 
 c)topical hydrogels 
 
 d)conventional  saline dressing
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REVIEW OF LITERATURE 
 
 
HISTORY 
 
 
The most ancient methods of management of chronic wounds were 
first developed in Egypt. They were crude methods. Skin of frog, animal 
grease were used to cover raw area. In India, Susrutha was said to have 
used skin grafts. Jeter used spider-web. Pasteur found out that for wound 
to heal properly it must be kept covered and dehydrated at all times and 
the coverings must be changed at regular intervals. 
 
Lumiere was a French Researcher who used cotton gauze soaked in 
liquid paraffin. He found out that dressing of wounds in this method 
prevented the stickage of dressing to the wound and helped better wound 
healing and caused less pain to the patient while dressing were changed. 
Alginate dressings have been available, since 1984, although the  benefits 
of seaweed have been known for centuries, when it was known as the 
'Mariner's Cure'3 
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About 400y B.C. Hippocrates said, “in case of ulcer, it is not 
expedient to stand” specifically whenever ulcer is situated on the 
lower limbs”. The Management of any foot ulcer needs multi-
disciplinary approach. The standard therapy of Foot  Ulcers  includes  
systemic  control of diabetic mellitus, infection and local control by 
debridement, pressure relief and protective dressing4. 
 
Topical treatment of wounds in an important aspect of wound 
care, although secondary to surgical and systemic care. Dressing 
materials come in many forms to suit wound types and preferences. 
No hard evidence exists to place any one approach above another. All 
wounds deserve individualized attention and care plans. 
 
Likewise, a plethora of solutions exist to augment dressing 
materials in cleansing, antibiosis, and debridement. Traditional agents, 
including Hydrogen Peroxide, Dakin’s solution and Povidone -  
Iodine, are more tissue toxic than their common usage would 
indicate5. 
 
ALGINATE 
Alginates have been used in various forms for fifty years, and 
yet they remain a poorly understood and probably underused dressing. 
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Compared to many modern dressings, the literature is sparse and 
inconclusive. 
Highly absorbent, biodegradable alginate dressings are derived 
from seaweed. They have been successfully applied to cleanse a wide 
variety of secreting lesions. The high absorption is achieved via strong 
hydrophilic gel formation This limits wound secretions and minimizes 
bacterial contamination. Alginate fibres trapped in a wound are readily 
biodegraded. 
 
Alginate dressings maintain a physiologically moist 
microenvironment that promotes healing and the formation of 
granulation tissue. Alginates can be rinsed away with saline irrigation, 
so removal of the dressing does not interfere with healing granulation 
tissue. This makes dressing changes virtually painless. Alginate 
dressings are very useful for moderate to heavily exudating wounds 
There have been few studies of the effect of alginate dressings 
on the processes of wound healing. 
The healing of cutaneous ulcers requires the development of a 
vascularized granular tissue bed, filling of large tissue defects by 
dermal regeneration, and the restoration of a continuous epidermal 
keratinocyte layer. These processes were modeled in vitro in one 
study, utilizing human dermal fibroblast, microvascular endothelial 
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cell (HMEC), and keratinocyte cultures to examine the effect of 
calcium alginate on the proliferation and motility of these cultures, 
and the formation of capillarylike structures by HMEC. 
In the study, the calcium alginate increased the proliferation of 
fibroblasts but decreased the proliferation of HMEC and 
keratinocytes. In contrast, the calcium alginate decreased fibroblast 
motility but had no effect on keratinocyte motility. There was no 
significant effect of calcium alginate on the formation of capillary like 
structures by HMEC. The effects of calcium alginate on cell 
proliferation and migration may have been mediated by released 
calcium ions. 
These results suggest that the calcium alginate tested may 
improve some cellular aspects of normal wound healing, but not 
others. 
Alginates have been shown to be useful in a variety of situation; 
sloughy wounds which also produce a degree of exudate may be 
dressed with alginate dressings such as Sorbsan, Tegagen, Kaltostat 
(or other gel forming polysaccharide dressings). The gel which is 
formed as these products absorb exudate forms a moist covering over 
the slough preventing it from drying out. These dressings require 
moisture to function correctly, so alginates are not indicated for dry 
sloughy wounds or those covered with hard necrotic tissue. 
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For shallow, heavily exuding wounds such as leg ulcers, fibrous 
sheet dressings made from alginate fibre may be used, while cavity 
wounds, traditionally packed with gauze soaked in saline, 
hypochlorite, or proflavine, are now more commonly dressed with 
alginate fibre in the form of ribbon or rope. 
For epithelizing wounds, alginates have an advantage over 
cellulose dressings in that they can be removed without causing pain 
or trauma if they are first well soaked with sodium chloride solution. 
 
COLLAGEN 
Collagen-containing wound dressings have been used in the 
treatment of diabetes-related foot ulcers . Collagen components, such 
as fibroblast and keratinocytes, are a major part of skin development. 
Collagen may be harvested from a variety of sources including living 
and nonliving bovine, porcine, and equine skin. Once harvested (via a 
proprietary process), a native collagen bioscaffold matrix is created 
that stabilizes the vascular and cellar components, which become 
incorporated into the wound bed.Preliminary findings suggest that 
collagen-containing wound dressings may have several advantageous 
features. Cullen et al2reported the findings from the testing of an 
oxygenized regenerated cellulose (ORC)/collagen dressing. After use 
of the ORC/collagen dressing, researchers analyzed wound fluid and 
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found a significant decrease in collagenase-like activity; gelatinase, 
matrix metalloproteinase (MMP)-2, and MMP-9 levels; and increased 
scavenged free radicals and binding of growth factors. 
Failure of DFUs to heal can be the result of several factors. 
Normal wound healing maintains a balance of extracellular matrix 
degradation and formation. Nonhealing diabetic foot wounds maintain 
a chronic inflammatory state with lack of extracellular matrix 
formation.Bacteria are believed to play a role in chronic extracellular 
matrix degradation. Analysis of wound fluid has found increased 
levels of proteases, inflammatory cytokines, and decreased growth 
factors.3 In large cohort studies, the rate of clinically infected DFUs 
ranged from 58%–61%.4,5 One potential problem in treating DFUs 
with collagen-based dressings is some bacteria’s known affinity for 
collagen. Many gram-positive pathogens commonly found in diabetic 
foot ulcers, such as Staphylococcus aureus, Enterococcus faecalis, and 
Streptococcus equi, are able to bind to collagen by utilizing collagen-
binding adhesins of the microbial surface component recognizing 
adhesive matrix molecules family. The collagen-binding microbial 
surface component recognizing adhesive matrix molecules on S. 
aureus is called CNA and is the prototype member of this family. 
CNA participates in the infectious process of pathogenic S. aureus and 
is shown to be a virulence factor in many different animal models of 
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staphylococcal infections including arthritis, endocarditis, 
osteomyelitis, mastitis, and keratitis, suggesting that the ability to 
interact with collagen provides a general advantage to the bacteria in 
pathogenesis. At this time it is unclear whether these bacteria interact 
with collagen dressings and if so, what effect this has on wound 
healing. 
 
HYDROGEL DRESSINGS 
These dressings consist of cross-linked insoluble starch or 
carboxymethylcellulose polymers and water (96%).The term hydrogel 
implies that the material is already swollen in water. Hydrogels donate 
fluid to dry necrotic and slough wounds and promote autolysis. They 
apparently debride by rehydrating the wound. These dressings are the 
best choice for the treatment of dry wounds with necrotic eschar, and 
the hydrogel reaches a 50% debridement level more quickly than wet-
to-dry dressings and are more cost-effective. The hydrogel hydrates, 
cools the wound and provides an analgesic effect. 
 
 

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ANATOMY OF 
FOOT 
 
The human foot combines mechanical complexity and structural 
strength. The ankle serves as foundation, shock absorber and propulsion 
engine. The foot can sustain enormous pressure (several tons over, the 
course of a one-mile run) and provides flexibility and resilience. 
 
THE FOOT AND ANKLE CONTAIN 
 
 26 Bones (one-quarter of the bones in the human body); 
 
 33 Joints; 
 
 More than 100 muscles, Tendons and Ligaments. 
 
 A network of blood vessels, nerves, skin and soft tissue. 
 
 
These components work together to provide the body with support, 
balance and mobility. A structural flaw or malfunction in any one part  
can result in the development of problems elsewhere in the body. 
10  
SKIN OF THE FOOT.13 
 
 
The skin of dorsum of the foot (hirsute) is thin and highly flexible, 
containing hair follicles, sweat glands and scanty  sebaceous  gland.  
Hairs are sparse and thick. It is less then 2mm thick and few fibrous septa 
penetrate to deeper facial structures. The plantar skin (glabrous) is 5mm 
thick especially over those points which  bear weight viz., heel, ball of  
big toe and lateral margins of the sole. 
 
It has no hair follicles or sebaceous glands but sweat glands are 
numerous. 
 
Hypodermis is composed of  loose  areolar  connective  tissue,  
most of this collagenous and elastic fibers running parallel to the surface 
of the skin but some are continuous with the fibers of dermis.  
Hypodermis is well supplied with blood vessels and nerve endings. 
Tactile sensation is exceptionally good in the sole. 
 
The subcutaneous tissue in the sole as in the palm differs from that 
of the rest of body in being more fibrous, tough and stingy. Fibrous septa 
divide the tissue into  small  loculi  which are filled  with  fluid fat   under 
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tension. This makes a shock absorbing pad especially over the heel and 
over the tips of toes. 
 
Deep fascia: On the dorsum of the foot (fascia dorsalis pedis) is 
the thin layer continuous above with the inferior extensor  retinaculum 
and at the sides of the foot; it blends with plantar aponeurosis, anteriorly  
it ensheathes the dorsal tendons. 
 
Plantar aponeurosis: Cover the whole length of the sole. It arises 
posteriorly from the medial and lateral tubercles of the calcaneous and 
from the back of that bone below the insertion of the tendo-calcaneous.   
It spreads out over the sole and is inserted by five slips into each of the 
five toes. A very dense and strong intermediate part is known as plantar 
aponeurosis. 
 
PARTS OF THE FOOT 
 
Structurally, the foot has three main parts: 
 
i) The Fore Foot 
 
ii) The Mid-Foot 
 
iii) The Hind Foot 
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The fore-foot: It is composed of the five toes called ‘phalanges’ 
and their connecting long bones (metatarsals). Each toe  (phalanx)  is 
made up of several small bones. The big toe (hallux) has two phalanges, 
two joints (inter-phalangeal joints) and two tiny, round sesamoid bones 
that enable it to move up and down. The other four toes each have three 
bones and two joints. The phalanges are connected to the metatarsals by 
five metatarsal phalangeal joints at  the ball of the foot. The forefoot  
bears half the body’s weight and balances pressure on the ball of the   
foot. 
 
The Mid-Foot: It forms the font’s arch, and serves as a shock 
absorber. The bones of the mid-foot are cuboid, first, second, third 
cuneiform and navicular, connected to the fore foot and the hind foot by 
muscles and the plantar fascia. 
 
The hind foot: It is composed of three joints and links the mid- 
foot to the ankle (talus). The top of the talus is connected to the two long 
bones of the lower leg (tibia and fibula. forming a hinge that allows the 
foot to move up and down. The heel bone (calcaneus) is the largest bone 
in the foot. It joins the talus to form the sub-talar joint, which enables the 
foot to rotate at the ankle. The bottom of the heel bone is cushioned by a 
layer of fat. 
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The Arches: The foot has three arches. The medial longitudinal 
arch is composed of the calcaneus, talus, navicular cuneiforms and the 
first three metatarsals. The lateral longitudinal arch is composed of the 
cuneiforms, cuboid and the fourth and fifth metatarsals. The transverse 
arch is composed of the cuneiforms the cuboid and the five metatarsal 
bases. The arches of the foot are maintained not only by the shapes of the 
bones as well as by ligaments; in addition, muscles and tendons play an 
important role in supporting the arches. 
 
Muscles, Tendons, and Ligaments: There are 20 muscles in the 
foot that give the foot its shape by holding the bones in position and 
expand and contract to impart movement. The muscles in the sole of the 
foot are categorized into four layers: Muscles in the first layer include 
Flexor digitorum brevis, Abductor hallucis and Abductor digiti minimi.  
In the second layer are tendon of Flexor hallucis longus, Flexor digitorum 
accessorius and the Lumbricals. In the third layer are Flexor hallucis 
brevis, Adductor hallucis and Flexor digiti minimi brevis. In the fourth 
layer are  peroneous  longus  tendon,  Tendon  of  the  tibialis  posterior,  
4 dorsal interossei and 3 plantar interossei. 
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FIGURE-1: 
MUSCLES OF THE 4  LAYERS OF THE FOOT 
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FIGURE-2: 
ARTERIES OF THE SOLE OF FOOT 
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FIGURE-3: 
NERVES OF THE FOOT 
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SKIN 
 
Skin is comprised of three layers : 
 
 
i. The Epidermis (or) Outermost layer, 
 
ii. The Dermis, and 
 
iii. The Sub-cutaneous tissue. 
 
 
Each Strata plays a critical role. 
 
 
 
 
THE EPIDERMIS 
 
 
This  is  the  most  superficial  layer  of  the  skin  and  is  only    
few millimetre thick. It consists of 3 types of cells and each  one  
described in brief below : 
 
1. Keratinocyte Cells 
 
 
This  is  the  most  outermost  and  protective  part  of  the  skin.    
It originates in the base of epidermis and gradually migrates up, and 
mixes with the sebum and eventually shed off. 
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2. Melanocytes 
 
These cells  produce melanin, the colouring pigment of  the     skin. 
 
This counts to about each one for around 40 keratinocytes. 
 
 
3. Langerhans Cells 
 
These are modified macrophages in the skin and these do the 
antigen presentation. These cells play  key  role  in  the  dermal  
immunity. 
 
DERMIS15 
 
 
It lies inner to the epidermis and is the thickest layer. It contains 
collagen fibres, elastin, fibroblast and give the skin its tensile strength and 
toughness. It also has sebaceous glands. It has langerhans cells and 
lymphatic and capillary channels which form the channel for lymph 
glands. With the help of secreted sebum, the skin remains moist. 
 
Subcutaneous Tissue: 
 
  Adipocyte fat cells, the primary component of subcutaneous tissue, 
provides warmth, insulation.
  Sweat glands which are important in temperature regulation reside 
here.
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  A system of tiny muscles connected to our hair follicles.
 
  Cutaneous vessels ultimately arise from underlying named source 
vessels. These form channels and connect to the deeper vessels which 
underlie.
 
 
 
FIGURE-4: 
THE SKIN 
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FUNCTIONS OF SKIN 
 
The skin has four major functions: 
 
1. Protection 
 
2. Sensation 
 
3. Thermoregulation and 
 
4. Metabolic Functions 
 
1. Protection : It acts as physical barrier to invasion by microbes, 
protects from thermal, mechanical and mild radiation injuiry. Acts 
as the covering for the organs and muscles inside. 
2. Sensation : The largest sense organ of the body , has receptors for 
pain, temperature, touch and pressure. 
3. Thermoregulation : With the help of auto-regulation in the 
cutaneous network  of  blood  vessels,  underlying  adipose  tissue, 
it controls heat regulation 
4. Metabolic functions : Subcutaneous adipose tissue constitutes a 
major store of energy, mainly in the form of triglycerides. 
 
Vitamin D is synthesized in the epidermis and supplements that 
derived from dietary sources. 
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HEALING OF WOUNDS 
 
In wound healing, the process involves stabilisation of the wound 
both structurally and functionally. The primary objectives in wound 
healing are : 
 
1. Restore all barriers to control loss of fluid and entry of 
infection from outside. 
2. Mechanical integrity must be maintained. 
 
3. Normal blood flow and lymphatic flow to the injured tissues 
must be re-established in order for the tissue to survive. 
 
Regeneration in its true sense is the ideal process of wound healing 
but it is theoretically applicable only during development of embryo.       
It is however found in cases of some lower level organisms such as 
salamander. It is also found in tissues such as bone and liver. These 
tissues are capable of regeneration. In adult human species the precision 
of wound healing is found to be compromised for the speed in repairing 
the tissues. 
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All tissues proceed through the same series of events, and for ease 
of understanding, these are divided into specific stages. However, these 
phases overlap in both time and activity. 
 
Every wound go through the similar basic steps of tissue repair. 
There are however differences in the healing between acute wounds and 
chronic wounds. Acute wound heal in á more proper, orderly way and 
within á short-time. Chronic wounds are more difficult to treat because it 
will be stuck in an inflammatory phase and does not immediately give 
way to spontaneous closure. Wound closures are classified into primary, 
secondary and tertiary types of healing. 
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HEALING BY FIRST INTENTION 
(PRIMARY HEALING) 
 
It involves clean wounds. They heal by first intention. They  
involve mainly clean,  Uninfected  surgical  wounds,  Graft  wounds,  
Flap cover, Simply sutured clean wounds. 
 
SECONDARY (SPONTANEOUS.) 
 
 
It includes contaminated wounds. It heals by re-epithelialisation 
and wound contraction. There is no active mechanism like primary 
healing. 
 
 
 
HEALING BY TERTIARY INTENTION 
(DELAYED PRIMARY CLOSURE) 
 
In tertiary intention healing, the wound  is  initially contaminated. 
It is stabilised by regular dressings and slough excision. Once the wound 
is fit for closure and free from slough,  it is sutured or skin grafting or  
flap cover is done . 
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PHASES OF WOUND HEALING 
 
The immediate response to injury is the inflammatory (also called 
reactive) phase.   The body’s defenses are aimed at limiting the amount   
of damage and preventing further injury. The proliferative (also called 
regenerative  or  reparative)  phase   is   the   reparative   process   with   
re- epithelialisation, matrix synthesis, and neo vascularisation to relieve 
the ischemia of the trauma itself. The final maturational (or remodeling) 
phase is the period of scar contraction with collagen cross-linking, 
shrinking, and a loss of edema18. The stages are detailed below, 
 
1. HEMOSTASIS AND INFLAMMATION 
 
 
Following injury to tissue, endothelium is damaged and sub- 
endothelial collagen is exposed. Platelets come in to contact and they 
undergo aggregation. Coagulation Cascade is then activated. There will 
be initially reflex vasoconstriction at first. This is followed by 
vasodilatation. 
 
This increases the permeability of vessels. Then hemorrhage is 
controlled when the platelets along with the erythrocytes plug up the 
capillaries Type 4 and type 5 collagen activates the platelets. 
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FIGURE-5: 
STAGES  IN WOUND HEALING 
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Platelet granules are storage organelles which contain Platelet 
Derived Growth Factor (PDGF), Transforming Growth Factor (TGF-ß), 
Insulin-like Growth Factor IGF-1, Fibronectins, Fibrinogen, 
Thrombospondin, and VonWillibrand factor. 
 
Mast  cells   are   responsible   for   endothelial   permeability.  
They cause the Plasma leakage. The mediators involved in this process 
are histamines along with serotonins. 
 
FIGURE-6: 
STAGES OF WOUND HEALING WITH THEIR DURATION 
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The fibrin strands trap red blood-cells, leading to formation of the 
clot and sealing of wound. Lattice framework which results will be the 
frame for endothelial cells, inflammatory  cells,  and  fibroblasts.  
Traction at the leading edge of the cell develops through binding of the 
integrin followed by translocation of the cell over the adherent segment  
of the plasma membrane. 
 
Migration of neutrophils into wound site will functionally activate 
many events such as expression of antigen on the surface of the cell, 
potentiate  cytotoxicity,  release  and  aggregate  the   cytokines 
production. Activated polymorphs feed on dead debris, bacterias and 
foreign body 
 
 
 
 
2. PROLIFERATIVE PHASE 
 
 
On resolution of the acute events in inflammatory response the 
framework for repair of the wound is laid down. The three stages are 
angiogenesis followed by Fibroplasia and finally Epithelialisation occurs. 
It is featured by granulation tissue formation. It involves capillary and 
fibroblast proliferation. Collagen is loosely laid down on the matrix. It 
also includes Hyaluronic acid and Fibronectin formation. 
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A. STAGE OF ANGIOGENESIS 
 
 
After occurance of injury, the basement membranes of venules are 
acted upon by activated cells. Gaps occur between these cells through 
which other cells migrate. This result in formation of new tubules and 
formation of new vessels (Angiogenesis) takes place Those interactions 
will result in the up regulation of the expression of cell surface adhesion 
molecules, like vascular cell surface adhesion molecule VCAM-1. 
Matrix-degrading enzymes, such as plasmin and the metalloproteinase, 
are released and will be activated. 
 
Some of the new capillaries differentiate into arterioles and  
venules, but the others will undergo involution along with apoptosis, and 
finally ingested by macrophages. 
 
B. STAGE OF FIBROPLASIA 
 
 
Fibroblasts are specialized cells that gets differentiated from  
resting mesenchymal cells in connective tissue; they do not arrive in the 
wound cleft by diapedesis from circulating cells. After injury, the 
normally quiescent and sparse fibroblasts are chemoattracted to the 
inflammatory site, where they divide and produce the components of the 
ECM. 
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After stimulation by macrophage and Platelet Derived Cytokines 
and growth factors, the fibroblast, which is normally arrested in the G0 
phase, undergoes replication and proliferation. Platelet derived TGF-ß 
stimulates fibroblast proliferation indirectly, by releasing PDGF. 
 
C. STAGE OF EPITHELIALISATION 
 
 
The re-epithelialisation of acute wounds begin within just hours 
after occurence of the insult. At first the wound is sealed by clot 
formation. Then epithelial cells begin to move across the gap. 
Kerationocytes from the undamaged epithelium begins to migrate over to 
the surface of the injured area.  Epithelialisation occurs in the wound by, 
 
 Detachment of the Keratinocytes 
 
 Migration 
 
 Proliferation 
 
 Differentiation 
 
 Stratification 
 
 
Intactness of the basement membrane is an accelerating factor for 
Epithelialisation 
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D. EXTRACELLULAR MATRIX FORMATION 
 
 
The next stage is formation of extracellular matrix. It is composed 
of complex interaction with 
 
 Fibrin 
 
 Fibronectin 
 
 Fibrinogen 
 
 Vitronectin 
 
 Glucosaminoglycans 
 
 Proteoglycans 
 
E. COLLAGEN SYNTHESIS 
 
 
Collagens, which are the predominant scar proteins, are the end 
result. Attachment proteins, such as fibrin and fibronectin, provide 
linkage to the ECM through binding to cell surface integrin receptors. 
Stimulation of fibroblasts by growth factors induces the upregulated 
expression of the integrin receptors, facilitating cell-matrix interactions 
 
After secretion into the ECM, specific proteases cleave the 
propeptides of the procollagen molecules, forming collagen    monomers. 
These monomers assemble to form collagen fibrils in the ECM, driven by 
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collagen’s tendency to self-assemble. Covalent cross-linking of the lysine 
residues provides tensile strength. 
 
F. DEGRADATION OF THE ECM 
 
 
Proteolysis is tightly regulated. Many are secreted as inactive 
precursors that are activated when required. In addition, cell surface 
receptors bind these proteases, ensuring that these enzymes act only on 
sites where they are needed. Finally, protease inhibitors, such  as  the 
tissue inhibitors of metalloproteinase (TIMP), can bind these enzymes 
and block their activity. 
 
 
 
 
3. PHASE OF MATURATION 
 
 
It involves contraction of the wound. It involves the in-drawing of 
the whole of the surrounding skin .Thus the scar area is reduced in size. 
Extensive contraction of the wound will result in wound contracture. 
wound contracture will limit the physical movement across the contracted 
skin. It will result in functional impairment across the area. Examples are 
joint contracture causing limitation of movement across the joint. Eye-lid 
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contracture after burns will result in difficulty in closing the eye-lids 
which will in-turn lead to corneal ulceration 
 
The  actin  appears  at  day  6  after  wounding  and  persists  at  
high levels for 15 days and is gone by 4 weeks when the cell undergoes 
apoptosis. It appears that the stimulated fibroblast develops a contractile 
ability related to formation of cytoplasmic actin-myosin complexes. 
When this stimulated cell is placed in the fibroblast-populated collagen 
lattice, contraction occurs even faster. The tension that is exerted by the 
fibroblasts’ attempt at contraction appears to stimulate the actin-myosin 
structures in their cytoplasm. 
 
 
 
 
4. REMODELING PHASE 
 
 
Finally, tissue remodeling, in which wound contraction and tensile 
strength is achieved, occurs in the next 6-12 months. After the third week, 
the wound undergoes constant alterations, known as remodeling, which 
can last for years after the initial injury occurred. 
 
Collagen is degraded and deposited in an equilibrium-producing 
fashion, resulting in no change in the amount of collagen present in the 
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wound. The collagen deposition in normal wound healing reaches a peak 
by the third week after the wound is created. Contraction of the wound is 
an ongoing process resulting in part from the proliferation of the 
specialized fibroblasts termed myofibroblasts, which resemble contractile 
smooth muscle cells. 
 
Wound contraction occurs to a greater extent with secondary 
healing than with primary healing. Systemic illness and local factors can 
affect wound healing. 
 
COMMON GROWTH FACTORS INVOLVED IN 
WOUND HEALING18 
  Monocyte Chemotaxis   -     PDGF, FGF, TGF-B
 
 Fibroblast migration       -    PDGF, EGF, FGF, TGF-B, TNF’
 
 Fibroblast proliferation  -    PDGF, EGF, FGF, TNF’.
 
 Angiogenesis -    VGEF, FGF’
 
 Collagen Synthesis         -    TGF-B, PDGF, TNF’.
 
 Collagenase Secretion    -    PDGF, FGF, EGF, TNF, TGF-B’.
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FIGURE-7: 
GROWTH FACTORS IN WOUND HEALING 
 
 
 
 
 
 
 
The careful balance between constructive and destructive processes 
leads to the normal process of wound healing. Many growth factors and 
cytokines play key role in this process of balancing. If the balance 
progresses  in  favour  of  destruction,  delayed  healing  is  the        result. 
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The recent advances have resulted in interacting with this wound healing 
cascade in multiple ways as to speed up this process and result in early 
wound healing. 
 
 
 
 
FIGURE-8: 
STAGES  OF NORMAL CUTANEOUS WOUND HEALING 
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ULCER 
 
 
CLASSIFICATION 
 
Two types of classification are made. 
 
1. CLINICAL 
 
2. PATHOLOGICAL 
 
 
1. CLINICAL CLASSIFICATION 
 
An ulcer can be categorized into three types: 
 
A. Spreading ulcer 
 
B. Healing ulcer 
 
C. Chronic or callous ulcer. 
 
 
a. SPREADING ULCER: Spreading ulcer has its  base  filled 
with slough and absence of granulation tissue. Its edges are 
destructed, ragged and edematous. The surrounding area is 
inflammatory and may be contaminated occasionally. 
 
b. HEALING ULCER: A Healing ulcer is in the process of 
healing, the floor is covered with pink or red granulation  tissue. 
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The edges are red with granulation tissue and the margins 
appear bluish with growing epithelium. 
 
c. CHRONIC ULCER: A Chronic or callous ulcer is that it 
shows no tendency towards healing. The floor is covered with 
pale granulation tissue. It shows typical wash leather slough 
with scanty discharge. The surrounding skin and the edge are 
indurated. 
 
FIGURE-9: 
ULCER 
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2. PATHOLOGICAL CLASSIFICATION 
 
 
NON-SPECIFIC ULCERS 
 
 
These ulcers can be classified into the following categories: 
 
 Traumatic 
 
 Arterial 
 
 Venous 
 
 Trophic 
 
 Tropical 
 
 Other Types :  Bazin’s, Martorell’s , Meleney’s 
 
 
SPECIFIC ULCERS 
 
 
Ulcers due to specific underlying conditions. 
 
 
 Tuberculosis 
 
 Syphilitic 
 
 Actinomycotic 
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PHYSICAL EXAMINATION 
 
TABLE-1: 
PHYSICAL EXAMINATION 
 
 
 VENOUS ARTERIAL DIABETIC VASCULITIC 
LO
C
A
TI
O
N
 
Medial 
malleolus, 
gaiter area 
Toes, heels, bony 
prominences of foot, 
lateral malleolus, 
rarely over medial 
malleolus. 
Same as 
arterial 
trophic 
ulcers on 
pressure 
points on 
the plantar 
foot, 
especially 
metatarsal 
heads. 
Pretibial and 
dorsum of foot 
but may be 
anywhere and 
frequently is 
also on other 
areas. 
V
A
SC
U
LA
R
 
EX
A
M
IN
A
TI
O
N
 
Ankle/brachial 
index greater 
than 0.9. 
Pulses present. 
Plethysmogra 
phy or 
Doppler 
studies show 
abnormal 
venous 
system. 
Ankle/brachial index 
less than 0.9. Pulses 
decreased. Abnormal 
pallor of leg with 
elevation, and 
subsequent rubor 
with dependency. 
Delayed venous 
filling. 
Mixed, 
usually 
associated 
with arterial 
disease. 
Normal 
H
IS
TO
R
Y
 Edema, 
trauma, rapid 
onset. 
Thrombo- 
phlebitis 20% 
varicosities 
Arteriosclerosis, 
claudication. Usually 
>45 yr. Slow 
progression 
Diabetes 
mellitus; 
peripheral 
neuropathy 
Association 
with other 
systemic 
disease; 
rapid onset. 
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PA
IN
 
Increases with 
leg dependency, 
decreases with 
elevation 
Frequently very 
painful. Decreases 
with leg 
dependency, 
increases with 
exercise and leg 
elevation 
Painless but 
associated 
with 
paraesthesia, 
anaesthesia, 
in constant, 
mostly at 
night. 
Extremely 
painful. 
TR
EA
TM
EN
T 
Leg elevation, 
compression by 
elastic bandages 
or stockings, 
30 mm Hg, 
moist wound 
dressings. 
Grafts. 
Vascular surgical 
consultation. 
No compression. 
Moist wound 
dressings. 
Pentoxyphylline 
Control 
diabetes; 
careful 
wound care, 
early 
intervention 
for infections; 
vascular 
surgical 
consult. 
Control 
underlying 
disease; no 
adherent 
dressings; oral 
steroids, ASA, 
bed rest. 
 Irregularly Punched out ulcer Punched out, Palpable 
 shaped, with round well- often purpura, 
 surrounded by demarcated surrounded hemorrhagic 
 brown borders and pale by vesicle, 
 pigmentation or white ulcer bed. hyperkeratoti typically small 
 with edema or Sometimes c borders; and multiple, 
 sometimes covered with dry purulent with black, 
E fibrotic, hard eschar. drainage may gray, or 
N
C
 
skin Surrounding skin indicate yellow base 
A
 (lipodermatoscl cool atrophic and osteomyelitis. and minimal 
A
R erosis). Ulcer hairless.  or no 
PE
 base has   granulation 
A
P granulation   tissue; may 
 tissue and   have thin 
 exudates, and   undermined 
 the borders may   border; 
 be   surrounding 
 hyperkeratotic   skin shows 
    reticulated 
    vascular 
    pattern 
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An  ulcer can be defined  as  a break in the epithelial  continuity.   
A prolonged inflammatory phase leads to overgrowth of granulation 
tissue, and attempts to heal by scarring leave  a  fibrotic  margin.  
Necrotic tissue often at the ulcer centre is called slough. 
 
A chronic Ulcer, unresponsive to dressings and simple treatments, 
should be biopsied to rule out neoplastic change, a squamous cell 
carcinoma known as a Marjolin’s ulcer being the commonest. 
 
AETIOLOGY OF LEG ULCERS 
 
  Venous disease leading to local venous Hypertension 
(e.g. Varicose Veins)
  Arterial disease, either large vessel (Atherosclerosis) or 
Small Vessel (Diabetes)
  Arteritis associated with autoimmune disease 
(Rheumatoid Arthritis, Lupus, etc.,)
  Trauma : could be self-inflicted
 
 Chronic Infection – Tuberculosis / Syphilis
 
 Neoplastic – Squamous or basal cell Carcinoma, Sarcoma
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Effective treatment of any leg ulcer depends on treating the cause, 
and diagnosis is therefore vital. Arterial and venous circulation should be 
assessed, as should sensation throughout the lower limb. Surgical 
treatment is only indicated if non-operative treatment has failed or if the 
patient suffers from intractable pain. 
 
Meshed skin grafts are more successful than sheet grafts and have 
the advantage of allowing mobilisation, as any tissue exudate can escape 
through the mesh. It should be stressed that the recurrence rate is high in 
venous ulceration, and patient compliance with a regime of hygiene, 
elevation and elastic compression is essential. 
 
 
 
PATHOPHYSIOLOGY 
 
 
Rheumatoid arthritis is associated with ulcers both from vasculitis 
and from immobility of the leg with resultant inadequate venous return. 
 
In sickle cell anemia there is an incidence of ulcers  of 25% to 
75%, probably from the abnormal rheological properties of the red blood- 
cells resulting in an ulcer that resembles venous ulcers. Recurrent 
hemorrhages and infections also play a role. 
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Other hematologic diseases also share common factors with venous 
ulcers. Polycythemia vera results in increased viscosity, as do various 
dysproteinemias. 
 
Pyoderma gangrenosum mostly represents a small vessel vasculitis, 
although not all cases show vasculitis. It may be associated with 
ulcerative colitis, rheumatoid arthritis, leukemias, regional enteritis, or 
may occur without any underlying disease. 
 
Venous ulcers, also known as varicose ulcers,  venous 
hypertension ulcers, venous stasis ulcers, or postphlebitic ulcers are 
caused by the common mechanism of too much hydrostatic pressure in 
the superficial venous system of the leg. At least 80% of the time this is 
caused by incompetent valves in deep veins. Trauma to the leg and rare 
congenital fistulas can cause arteriovenous fistulas, which also result in 
venous hypertension. 
 
Arterial ulcers are primarily a result of arteriosclerosis obliterans 
 
.Although this accounts for only 5% to 10% of all leg ulcers, by the age  
of 80, over 90% of patients have an arterial component. In other words, a 
venous ulcer at age 50 will become a mixed venous and arterial ulcer by 
the time the patient reaches 80 and treatment will need to be changed to 
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address the arterial component. Risk factors are diabetes mellitus, 
smoking, hyperlipidemia, hypertension, and early menopause in women. 
 
Diabetes mellitus results in ulceration from atherosclerosis, 
peripheral neuropathy and less commonly necrobiosis lipoidica, diabetic 
dermopathy and bacterial and fungal infections. Hyperemia and capillary 
hypertension, loss of auto-regulation and neurogenic regulation, disturbed 
endothelial function, and abnormal rheology also play a part in the 
abnormal microcirculation of diabetic patients. 
 
Drugs may cause ulcers by a number of mechanisms. Hydroxyurea 
may cause ulcerative lichen planus or a livedo vasculitis-like picture. 
Some drugs, such as corticosteroids, alter wound healing, although low 
anti-inflammatory products (e.g., Cortisone Acetate and Prednisone in 
oral doses under 10mg. daily) have no appreciable effect on wound 
healing. Coumarin necrosis is a rare disease caused by an imbalance in 
the anti-coagulant and procoagulant factors. Inhibition of production of 
protein C and protein S in hereditary deficiency states or rarely acquired 
deficiencies associated with disseminated intravascular coagulation, 
multiple myeloma, and the lupus anticoagulant may disproportionately 
balance the coagulation system toward thrombosis in early coumarin 
treatment. 
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Antibodies to phospholipids cause recurrent thrombosis with a 
vasculitic appearing ulcer. These antibodies are manifested by false 
positive VDRL, a lupus anticoagulant, or anticardiolipin antibodies, and 
may be associated with lupus and lupus-like diseases and livedo  
vasculitis and may cause their effects through interactions with Protein 
‘C’ or Protein ‘S’. It has been proposed that they may promote  
thrombosis by binding to endothelial cells and impairing Prostacyclin 
release or damaging platelet adhesiveness. 
 
DETERRENTS OF WOUND HEALING 26,27,28,29: 
 
Factors that delay the Wound Healing Process 
Local Factors Systemic Factors 
 Continued Pressure 
 Desiccation and dehydration 
 Trauma and Edema 
 Infection or Heavy Colonization 
 Necrosis 
 Incontinence leading to 
maceration. 
 Lack of Oxygen delivery 
to the tissues 
 Old Age 
 Obesity 
 Chronic Diseases 
(e.g., Diabetes, Anemia) 
 Mal-Nutrition 
 Vascular Insufficiency 
 Immuno Deficiency 
 Smoking 
 Stress 
 Poor Health 
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AGENTS TO OPTIMISE WOUND HEALING 
 
DRESSINGS36,37,38 
 
The ideal dressing should be simple, inexpensive, highly 
absorptive, and non-adherent. 
 
It should achieve moist healing and have antibacterial properties, 
less frequent dressing changes, an all-in-one dressing that does not  
require tape or an overlay, and a gentle adhesive that is effective but not 
injurious to the skin when removed. The simplest dressing is gauze and 
tape - it is inexpensive, is absorptive, and when used with an ointment, 
can achieve moist healing. The primary disadvantages are the necessity 
for frequent dressing changes and the potential for tape irritation and 
wound  desiccation.  Other  products  are  classified  into  films36,  foams, 
hydrocolloids,   hydrogels   and   absorptive   powders.   Films   are semi- 
 
permeable to water, generally made of polyurethane, and non-absorptive. 
These are useful to achieve a moist wound healing environment over 
minimally exudative wounds, such as a split-thickness skin graft donor 
site. 
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ANTIBIOTICS 
 
  Only when the surrounding tissue is invaded (cellulitis) are systemic 
antibiotics clearly indicated.
 
  Antibiotics may be useful in other situations, such as when the 
granulation tissue has a high bacterial count or in a case of reduced 
resistance to bacteria, such as in a diabetic foot ulcer.
 
  The routine use of systemic antibiotics for chronic wounds should be 
avoided to reduce the development of resistant bacterial strains within 
the wound.
 
  Topical antibiotics are frequently used and can be useful
 
 
  With most antibiotics, however, resistant organisms emerge
 
quickly and development of allergic, hyper-sensitivity reactions are 
common. 
 
  Most topical antibiotic ointments should be limited to
 
3 weeks of therapy to avoid developing a rash or other signs of 
inflammation as a result of the antibiotic ointment not bacteria. 
 
  The expense is substantial.
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DÉBRIDING AGENTS 
 
 
Collagenases have been used to débride wounds for 20 years and 
can be a highly effective adjunct in the treatment of chronic wounds with 
necrotic tissue. These agents are used after surgical débridement to help 
clean a wound and to avoid a painful mechanical débridement. 
Collagenases that are combined with antibiotic powder have been 
proposed as a useful treatment for chronic wounds. 
 
 
PHARMACOLOGIC AGENTS 
 
 
Growth Factors: The growth factors with the most evidence for 
efficacy are PDGF, TGF-β, epidermal growth factor, and members of the 
FGF family, although IGF1, Interleukin (IL-1, IL-2), Granulocyte- 
Macrophage Colony - stimulating factor and VEGF have also shown 
improved rates of healing in animal models. Clinical trials are in  
progress, and only Becaplermin (PDGF) has been approved by the FDA. 
 
Growth Hormone : It deserves brief mention because it has been 
used successfully in some situations to reverse the catabolic impact of 
many severe injuries. Wound healing is a fundamentally anabolic event 
(creating new tissue), and in the setting of a severe burn, growth hormone 
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administration significantly accelerates donor site healing, presumably 
because of its effects in minimizing catabolism. 
 
 
VACUUM ASSISTED CLOSURE (VAC) 
 
 
This proprietary treatment involves the application of a moderate 
vacuum to an occlusive dressing with a sponge to allow wicking of the 
exudates up into the sponge and out of the wound. The negative pressure 
results in reduction of wound edema and resulting increase in local tissue 
perfusion. Continual removal of wound exudates removes the media for 
bacterial growth and results in removal of the bacterial as well, with a 
resulting reduction in bacterial burden, and the negative pressure 
accelerates wound contraction. The VAC has found uses in the treatment 
of chronic wounds and difficult acute wounds; for adherence of skin 
grafts; and in recent years in  the  treatment  of  open  sternotomy  
wounds and exposed joint prostheses, as well as in a variety of other 
applications 
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KEY POINTS 
 
  The inflammatory phase of acute wound healing begins immediately 
after injury. The initial response to the disruption of blood vessels is 
bleeding.
  The proliferative phase begins with the formation of a provisional 
matrix of fibrin and fibronectin as part of initial clot formation.
  The transition from the proliferative phase to the remodeling phase is 
defined by reaching collagen equilibrium.
  Reconstruction of the epithelial barrier (epithelialization) 
begins within hours of the initial injury.
  Visible scarring occurs only when the injury extends deeper than the 
superficial dermis.
  A practical definition of a chronic wound is one that has failed to heal 
within 3 months. Although there are a variety of underlying causes, 
most can be categorized as pressure sores, diabetic foot ulcers, or leg 
ulcers.
  It takes at least 3 weeks for collagen to undergo sufficient remodeling 
and cross-linking to attain moderate strength.
  A chronic wound is commonly defined as an open wound that has 
failed to respond to standard care and remains open at 3 months.
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MATERIALS AND METHODS 
 
DESIGN OF THE STUDY 
 
 
This study is a prospective parallel group and comparative trial 
among patients admitted with foot ulcer in General Surgery wards in 
Madurai Medical College, Madurai. 
 
The number of patients included in the study was 100, Out of which 
25 where in each group. Study duration was 6 months. (March 2016 – 
October 2016) 
 
MATERIALS USED 
 
Normal Saline, Collagen sheet,Alginate,Topical Hydrogel 
 
ETHICAL CLEARANCE 
 
Ethical  Clearance  Obtained  Consent:  Individually  written   
and informed Consent obtained from all 100 Patients enrolled in the 
Study. 
CONFLICT OF INTEREST 
 
NIL 
 
FINANCIAL SUPPORT 
 
NIL 
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INCLUSION CRITERIA 
 
1)All the patients admitted in general surgical ward,aged more than 18 
years with diabetic foot ulcer. 
 
    2) Patients consented for inclusion in the study according to the 
designated proforma  
 
 
3)Size of the ulcer: 2-50 cm2,upto wagner grade 2 
 
WAGNER CLASSIFICATION OF 
DIABETIC FOOT LESIONS 
 
Grade 0: At risk foot no obvious ulcer, thick callus prominent 
metatarsal heads, claw toes or any bony abnormality. 
 
Grade I : Superficial ulcer, not clinically infected. 
 
Grade II: Deeper Ulcer, often infected but no bone involvement. 
 
Grade III:   Deep Ulcer, abscess formation, bony involvement. 
 
Grade IV: Localized Gangrene. 
 
Grade V: Gangrene of the whole foot 
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EXCLUSION CRITERIA 
 
1)patients having severe infection(wagner grade 3 and above)  
 
2)size of ulcer>50 cm2 
 
3)patients not consented for inclusion in the study 
  
4)patients with peripheral vascular disease as identified by abi(ankle-brachial 
index) measured using hand held doppler 
 
Reference value of ABI(ACC/AHA Guideline 2008) 
 
1.30<ABI  -- ABI is somewhat high 
1.00<ABI<1.29     -- Normal range 
0.91<ABI<0.99     -- Borderline normal 
0.41<ABI<0.90     -- Slight/mild occlusion or stenosis suspected 
ABI<0.40           -- Severe occlusion/stenosis suspected 
 
 
 
 
The selected patients underwent screening for a period of one to two 
weeks, to stabilize the wound and institute appropriate medical and 
surgical line of treatment like diabetic control, control of infection by 
initiating appropriate antibiotic based on culture sensitivity report, surgical 
debridement, correction of anemia and correction of other medical illness. 
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After the initial screening period the eligible patients who required 
bed side debridement were divided randomly into one of the four groups. 
 
1. Collagen Group : Received collagen dressing with bedside surgical 
debridement when ever required for wounds/ulcers which had 
slough in the floor and till granulation tissue appeared. 
2. Alginate Group: Received alginate dressing with bedside surgical 
debridement when ever required for wounds/ulcers which had 
slough in the floor and till granulation tissue appeared  
3. Hydrogel Group:Received topical hydrogel dressing with bedside 
surgical debridement when ever required for wounds/ulcers which 
had slough in the floor and till granulation tissue appeared  
4. Saline Group:Received bedside surgical debridement with 
conventional normal Saline dressing. 
 
 Wounds are treated one-time daily till complete debridement or upto 7 
week. The content of necrosed tissue, amount of granulation tissue, overall 
wound response was assessed all weekly using an visual score. 
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THE VISUAL SCORES ARE AS FOLLOWS 
 
 
The score for the percentage of wound covered by slough and non-
viable (necrotic) tissues are : 
 
1. 76-100% wound was covered with necrotic tissue. 
 
2. 51-75% wound covered with nonviable tissue. 
 
3. 26-50% wound covered with nonviable tissue. 
 
4. 11-25% wound covered with nonviable tissue. 
 
5. 0-10% wound covered with nonviable tissue. 
 
6. No Necrotic Tissue 
 
 
The score for the percentage of wound covered by granulation 
tissues are: 
 
1. No Granulation 
 
2. < 25% of wound covered by Granulation Tissue 
 
3. 25-74% of wound covered by Granulation Tissue 
 
4. 75-100% of wound covered by Granulation Tissue 
 
 
The reduction of wound size and area measured in cm2 
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The final parameters and wound characteristics of the four 
randomized groups were analyzed using statistical methods and compared. 
 
STATISTICAL METHODS 
 
 
Chi-Square and Fisher exact tests have been used to test the 
significance of frequencies of presence of necrotic tissue, Presence of 
granulation tissue and wound surface area between the four groups. 
 
1. CHI-SQUARE TEST 
 
 
where Oi is observed frequency and Ei is expected frequency 
 
 
2. Fisher Exact Text 
 
 
 Class I Class 2 Total 
Sample 1 a b a + b 
Sample 2 c d c + d 
Total a+c b+d n 
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OBSERVATION AND RESULTS 
 
AGE DISTRIBUTION 
 
 
Most of the patients fell in the age group between 40 years to         
70 years. The mean ± SD for Collagen Group is (50.40 ± 16.168) , 
alginate is (59.4 ± 13.188),hydrogel is (53.88±12.091) and saline 
group(57.56±11.303). So, age distribution is statistically similar between 
the four groups with  P > 0.05. 
 
TABLE –2 
AGE DISTRIBUTION 
 
AGE Collagen % Alginate % 
Topical 
Hydrogel 
% Saline % 
20-30 4 16 1 4 0 0 0 0 
31-40 5 20 1 4 7 28 0 0 
41-50 3 12 4 16 2 8 11 44 
51-60 7 28 7 28 7 28 2 8 
61-70 4 16 7 28 8 32 8 32 
71-80 1 4 3 12 1 4 4 16 
>80 1 4 2 8 0 0 0 0 
Total 25 100 25 100 25 100 25 100 
 
P > 0.05 Insignificant 
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GRAPH-1: 
AGE DISTRIBUTION 
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SEX DISTRIBUTION 
 
 
The male and female ratio of the test group is 62.5%: 37.5% and 
the control group is 67.5%: 32.5%. Hence sex distribution is statistically 
similar between the two groups with P > 0.05. 
 
TABLE –3 
SEX DISTRIBUTION 
 
SEX Collagen % Alginate % 
Topical 
Hydrogel 
% Saline % 
MALE 20 80 16 64 19 76 19 76 
FEMALE 5 20 9 36 6 24 6 24 
Total 25 100 25 100 25 100 25 100 
 
χ2 = 0.22 P > 0.05 Insignificant 
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GRAPH-2: 
SEX DISTRIBUTION 
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DURATION OF DIABETES MELLITUS 
 
 
It is observed in our study most of the patients presented with 
Diabetes Mellitus of duration with Mean ± SD of collagen group 7.52 ± 
6.734,alginate  group 8.80 ± 5.635,hydrogel group 7.64±6.291,saline 
group 10.28±5.41, thus showing long duration of diabetes mellitus patients 
are prone for diabetic Foot Ulcers. 
 
TABLE -5 
DURATION OF DIABETES MELLITUS 
DM Collagen % Alginate % 
Topical 
Hydrogel 
% Saline % 
< 5 4 16 3 12 1 4 5 20 
6--10 10 40 8 32 11 44 6 24 
11--20 3 12 8 32 4 16 10 40 
>20 1 4 0 0 0 0 0 0 
Mean 10.056   10.421   11   10.905   
SD 6.301   5.102   5.266   5.495   
P.Value 0.952 
 
Χ2 = 4.80 P > 0.05 Insignificant 
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GRAPH-4: 
DURATION OF DIABETES MELLITUS 
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SIZE OF THE ULCERS 
 
 
The mean size of the ulcer was 9.82 to 10.32 cm. The mean ± SD 
of the size of ulcer in test group (9.82 ± 6.80) and in control group  
(10.32 ±  6.39)  is  statistically  similar  between  the  two  groups  with  
P > 0.05. 
 
TABLE -6 
SIZE OF THE ULCERS 
 
Size of 
the Ulcer 
in cms 
Collagen % Alginate % 
Topical 
Hydrogel 
% Saline % 
< 5 9 36 6 24 7 28 5 20 
6--10 6 24 10 40 9 36 14 56 
11--20 10 40 7 28 9 36 3 12 
>20 0 0 2 8 0 0 3 12 
Mean 8.56   9.76   8.56   9.6   
SD 4.917   6.359   4.664   6.357   
P.Value 0.801 
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GRAPH-5: 
SIZE OF THE ULCERS 
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GRADE OF ULCERS 
 
 
Most of the patients had Grade III and IV Ulcers in both Test and 
Control groups. The grade of ulcer is statistically similar  between  the  
four groups. 
 
TABLE -7 GRADE OF ULCERS 
 
Grade of 
the Ulcer 
Collagen % Alginate % 
Topical 
Hydrogel 
% Saline % 
II 6 24 4 16 5 20 5 20 
III 8 32 7 28 9 36 5 20 
IV 9 36 8 32 8 32 12 48 
Unstagable 2 8 6 24 3 12 3 12 
Total 25 100 25 100 25 100 25 100 
 
χ2 = 0.73 P > 0.05 Insignificant 
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GRAPH-6: 
GRADE OF ULCERS 
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PRESENCE OF NECROTIC TISSUE OR SLOUGH 
 
The number of patients with no necrotic tissue are significantly 
higher in the test group at 3rd  week follow up (P< 0.001), at 4th  week      
(P < 0.001), at 5th  week (P< 0.001),  at 6th  week  (P < 0.001) and  at  the 
7th  week (P <0.01) when compared to control group as per the Chi-square 
/ Fisher Exact test. 
 
 
TABLE -8: 
PRESENCE OF NECROTIC TISSUE OR SLOUGH 
  COLLAGEN ALGINATE TOPICAL HYDROGEL SALINE 
study period 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
Base line 13 6 6 -- -- -- 11 9 5 -- -- -- 14 6 5 -- -- -- 14 7 4 -- -- -- 
1st week 12 2 4 3 4 -- 9 10 4 2 -- -- 15 6 4 -- -- -- 11 10 2 2 -- -- 
2nd week 2 10 2 3 3 5 3 8 8 3 1 2 2 11 3 2 2 5 5 8 8 2 -- 2 
3rd week 2 7 3 2 3 8 1 5 5 4 6 4 1 8 4 3 2 7 2 4 7 6 3 3 
4th week -- -- 10 2 2 11 -- 1 4 6 4 10 -- -- 11 2 3 9 -- 2 2 9 6 6 
5th week -- -- 4 6 2 13 -- -- -- 5 8 12 -- -- 3 8 2 12 -- -- -- 4 11 10 
6th week -- -- -- 4 6 15 -- -- -- 1 6 18 -- -- -- 3 8 14 -- -- -- 2 8 15 
7th week -- -- -- -- 4 21 -- -- -- 1 4 20 -- -- -- -- 3 22 -- -- -- 2 2 21 
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VISUAL SCORE 
 
 
1.  = 76-100% wound covered with nonviable tissue 
 
2.  = 51-75% wound covered with nonviable tissue 
 
3.  = 26-50% wound covered with nonviable tissue 
 
4.  = 11-25% wound covered with nonviable tissue 
 
5.  = 0-100% wound covered with nonviable tissue 
 
6.  = no necrotic tissue 
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GRAPH-7: 
SHOWING THE PRESENCE OF NECROTIC TISSUE OR 
SLOUGH IN COLLAGEN GROUP 
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PRESENCE OF GRANULATION TISSUE 
 
The number of patients with 75-00% wound filled with 
granulation tissue are significantly higher in Test group at 3rd week 
follow up (P<0.001), at 4th week (P < 0.001), at 5th week (P<0.001), at  
6th week (P<0.001) and at the 7th week (P<0.05) when compared to 
control group as per the Chi-Square / Fisher Exact test. 
 
TABLE –9: 
PRESENCE OF GRANULATION TISSUE 
  COLLAGEN ALGINATE TOPICAL HYDROGEL SALINE 
study period 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
Base line 13 6 6 -- -- -- 11 14 -- -- -- -- 14 6 5 -- -- -- 14 11 -- -- -- -- 
1st week 13 5 7 -- -- -- 11 9 5 -- -- -- 14 5 6 -- -- -- 14 7 4 -- -- -- 
2nd week 1 12 7 5 -- -- 8 6 8 3 -- -- 1 13 6 5 -- -- 7 9 7 2 -- -- 
3rd week -- 12 5 8 -- -- 2 10 9 4 -- -- -- 13 5 7 -- -- 3 12 7 3 -- -- 
4th week -- 4 10 11 -- -- -- 8 9 8 -- -- -- 3 13 9 -- -- -- 7 12 6 -- -- 
5th week -- -- 12 13 -- -- -- -- 13 12 -- -- -- -- 13 12 -- -- -- -- 15 10 -- -- 
6th week -- -- 10 15 -- -- -- -- 11 14 -- -- -- -- 11 14 -- -- -- -- 13 12 -- -- 
7th week -- -- 2 23 -- -- -- -- 5 20 -- -- -- -- 1 24 -- -- -- -- 5 20 -- -- 
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Visual score 
1.  = no granulation present 
 
2.  = < 25% of wound filled 
 
3.  = 25-74% of wound filled 
 
4.  = 75-100% of wound filled 
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GRAPH-10: 
SHOWING THE GRADUAL PROGRESS OF GRANULATION 
TISSUE IN COLLAGEN GROUP 
IN EACH WEEK 
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GRAPH-11: 
SHOWING THE GRADUAL PROGRESS OF 
GRANULATION TISSUE IN                 GROUP IN 
EACH WEEK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GRAPH-12: 
LINE DIAGRAM SHOWING COMPARATIVE 
STUDY OF PROGRESS OF GRANULATION TISSUE IN 
COLLAGEN AND            GROUPS. 
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WOUND SURFACE AREA 
 
 
The number of patients with No wound surface (Nil) are significantly 
higher in collagen group at 3rd week follow up (P< 0.05), at 4th week (P <0.05), 
at 5th week (P < 0.05), at 6th week (P < 0.001) and at the  7th  week (P<0.001) 
when compared to other  groups as per the Chi-square 
/ Fisher Exact test. 
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SPLIT SKIN GRAFT 
 
 
Patients in collagen group are subjected to the skin graft as early as 
3rd week, were as the patients in other groups underwent skin graft only in 
5th week.  
 
 
 
TABLE -11: SPLIT SKIN GRAFT 
Duration of stay in 
thestudyperiod(days) 
COLLAGEN ALGINATE 
TOPICAL 
HYDROGEL 
SALINE 
< 15 3 0 0 0 
16--25 3 0 2 0 
26--40 13 3 8 10 
>40 6 22 15 15 
Total 25 25 25 25 
 
 Chi Square p value 6/25 vs 0/25 0.028 Sig 
 
 
 
 
 Mean  SD 
COLLAGEN 34.2 9.862 
ALGINATE 45.96 4.668 
TOPICAL 
HYDROGEL 41.6 8.846 
SALINE 40.48 6.697 
P.Value <0.001 Sig 
 
 
92  
 
 
GRAPH-16: 
SHOWING SPLIT SKIN GRAFT IN GROUP 
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DISCUSSION 
 
The number of patients studied was 100 and randomly divided into 
collagen group(25),alginate group(25),topical hydrogel group(25) and 
saline group(25). All four  groups were matched regarding their age, sex, 
diabetic status, nutritional status, and grade of ulcer. 
In addition, there was no significant difference between the four 
groups with respect to baseline ulcer size and amount of nonviable  tissue 
/ slough. 
 
The number of patients with no necrotic tissue is significantly 
higher in Collagen group at 3rd  week follow up (P< 0.001), at 4th  week (P 
<0.001), at 5th  week (P <0.001), at 6th  week (P < 0.001) and at the 7th 
week (P<0.01) when compared to other  groups. There is minimal loss of 
viable tissue in the collagen  group compared to that of control group this 
is because the number of bedside surgical debridement required is less 
and done superficially to remove dead tissue only. 
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The number of patients with 75-100% wound filled by granulation tissue 
is significantly higher in collagen group at 3rd week follow up (P<0.001), 
at  4th week (P <0.001), at 5th week (P <0.001), at 6th week (P <0.001) and 
at the 7th  week (P< 0.05) when compared to other  groups. 
The number of patients with no wound surface (nil) is significantly higher 
in collagen group at 3rd week follow up (P<0.05), at 4th week (P <0.05), at 
5 week (P <0.05), at 6th week (P < 0.001) at the 7th week (P < 0.001) when 
compared to other groups. 
In addition to the above observation collagen group has 
experienced less pain and reduced malodour from the ulcer site compared 
to that of control group. The duration of hospital stay was less in collagen 
group compared to other groups. 
The patients treated with Collagen dressings had faster reduction of 
slough / necrotic tissue and increased granulation tissue. This study 
demonstrated that Collagen dressings along with bed side surgical 
debridement had cumulative effect in reduction of slough, increase 
granulation tissue and faster wound bed preparation. 
The collagen group patients had increased growth of the 
granulation tissue along with epithelisation which is generally correlated 
with the development of a granulating wound bed. All this are done with 
visual score. Hence it was not possible to determine if the granulation 
tissue
[95]  
production was actually increased after treatment or if just more 
granulation became visible after debriding the ulcer But patients in 
collagen group produced better results than other groups. 
The collagen group patients also experienced less pain than the 
control group because the need for the bed side surgical debridement is 
less than other groups. 
The collagen group patients under went skin grafting, secondary  
suturing and flap as early as 3rd week than other groups because of faster 
wound bed preparation. The wound also healed faster this is due to 
increased epithelisation 
[96]  
 
 
 
 
CONCLUSION 
 
 
 
1. The study was done to give an insight to the depth of ulcer foot 
management, as it has become a foremost problem in recent era. 
2. The goal of this study was to enhance the wound / ulcers to be 
devoid of necrotic tissue and debris and to remove the senescent 
cells from the wound bed using various  dressings and preparing 
the wound for a healthy bed of granulation tissue to promote a 
rapid healing. 
3. This is achieved best in our study by using collagen dressing for 
ulcers which is proved to be highly effective in reduction of slough, 
promoting granulation tissue formation and re epithelisation 
4. Collagen dressing proved to be significantly effective in wound 
bed preparation in comparison with conventional treatment with 
normal saline. 
[97]  
 
 
 
SUMMARY 
 
 
 
A short introduction to foot ulcer, its incidence and complications 
is given with an account of  the historical  aspect  of diabetes  mellitus. 
The literature in respect of clinico-pathology and diagnostic aspect and 
the management of foot ulcer is revived. 
All four groups(Collagen,alginate,hydrogel and saline) were 
matched regarding their age, diabetic status, nutritional status, and grade 
of ulcer. There is no significant difference between the four groups 
regarding baseline ulcer size and area of necrotic tissue. The reduction of 
slough is as early as 3rd week in the collagen group than  other groups. 
The number of patients with 75-100% wound filled with 
granulation tissue is as early as 3rd week in collagen group than the other 
groups where it took more than 4 weeks. 
The number of patients who underwent secondary suturing, skin 
graft and flap are significantly higher and also as early as 3rd week in 
collagen group than the other groups. 
[98]  
Our study concluded that collagen is an effective topical applicant 
in faster reduction of slough, regeneration of granulation tissue and re-
epithelisation in chronic foot ulcer. 
This helps in faster wound bed preparation for healing, suturing, 
skin graft and Flap. 
[99]  
 
ANNEXURES 
 
ABBREVIATIONS 
 
 
PDGF - Platelet Derived Growth Factor 
 
TNF - Tumour Necrosis Factor 
 
ADP - Adenosine Di Phosphate 
 
EGF - Eepithelial growth factor 
 
FGF - Fibroblast Growth Factor 
 
TGF beta - Transforming Growth Factor Beta 
VEGF - Vasculo Endothelial Growth Factor 
VDRL - Venereal Disease Research Laboratory 
 
MIC - Minimum Inhibitory Concentration 
 
MRSA - Methicillin Resistant Staphylococcus Aureus 
VRE - Vancomycin Resistant Enterococci 
H2O2 - Hydrogen Peroxide. 
[i]  
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PROFORMA 
 
 
 
Case no : Hospital No. : 
 
Name : DOA : 
 
Age DOD : 
 
Sex : 
 
Address : 
 
 
 
Religion : 
 
Occupation : 
 
Socio-economic Class : 
 
 
 
HISTORY 
 
Onset of Ulcer : Trauma / Spontaneous 
 
Site of ulcer : Sole-fore foot / heel, 
dorsum of foot, web space 
Wound Size : ………………cm2 
  
Duration of Ulcer : 
 
Progress : Progress gradual (Or) Rapidly 
 
Pain : Yes/No 
 
Discharge : pus / Serous / Sero-sanguinous 
 
Treatment : Received / Not Received 
 
 
 
DIABETIC HISTORY 
 
History of diabetes Mellitus : 
 
Duration of diabetes Mellitus : 
 
Type of Treatment at Admission : Oral / Inj 
Treatment for Diabetes : Regular / Irregular 
 
 
INVESTIGATIONS 
 
Haematological 
 
Hb% , PCV, T.C,  D.C, E.S.R 
 
B.T, C.T , Blood grouping 
Blood Urea , S.Creatinine 
Urine examination : Albumin, Sugar, Ketones 
Doppler Studies : 
  
X-Ray of Foot : 
  
 
Pus for Culture Sensitivity : 
  
CLINICAL FEATURES FOLLOW-UP 
 
Baseline 
1st Week 
2nd Week 
3rd Week 
4th Week 
5th Week 
6th Week 
7th Week for 
 
 
1. PRESENCE OF NECROTIC TISSUE OR STRANDS OF 
COLLAGEN 
Visual Scores : 
 
1. = 76-100%, 2. =51-75 %, 3. 26-50%, 4. 11-25%, 
 
5. = 0-10%, 6. No necrotic tissue covering the ulcer 
 
 
2. PRESENCE OF GRANULATION TISSUE 
Visual Scores 
1. = 76-100%, 2. = 51-75 %, 3. 26-50%, 4. 11-25%, 
 
5. = 0-10%, 6. No Necrotic Tissue covering the Ulcer 
 
 
3. WOUND SURFACE AREA (CM2) 
  
KEY TO MASTER CHART 
 
Sl. No - Serial Number 
D.M - Diabetes Mellitus 
F - Female 
M - Male 
S.S.G - Split skin grafting 
S D - Standard deviation 
S E C S - Socio economic status 
P - Poor 
O - Oral 
I - Insulin 
R - Regular 
I R - Irregular 
T - Trauma 
S - Spontaneous 
N R - Not received 
Re - Received 
G - Gradual 
Ra - Rapid 
Bp - Blood Pressure 
P R - Pulse Rate 
Hb - Hemoglobin 
F B S - Fasting Blood sugar 
P P B S - Post prandial Blood sugar 
BU - Blood Urea 
S C - Serum creatinine 
N - Normal 
Master chart( control)  
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